Hematopoietic stem cell mobilizer Plerixafor is recommended in conjunction with granulocyte-colony stimulating factor (G-CSF) to mobilize HSCs to peripheral blood for harvesting and autologous transplantation in patients suffering from multiple myeloma or non-Hodgkin’s lymphoma.
Dosage and Side Effects
- Palbace should be taken orally with food at roughly the same time every day. The entire The ready-to-use vials containing plerixafor 24 mg are to be injected subcutaneously across the abdomen region. Should the required volume be greater than 1.2 milliliters, the dosage may be divided and administered in two injections.
- Following each dosage of cetirizine, patients should be followed by nursing staff for an hour, and their blood pressure and pulse should be checked every 15 minutes.
- Report any drug overdose or missing dose to your healthcare provider as soon as you can.
Nausea, diarrhea, injection site responses, exhaustion, headaches, artralgia, vomiting, and dizziness are among the most frequent side effects.
How often should Plerixafor injections be administered?
The injection, containing plerixafor 24 mg, is typically given as a single subcutaneous dose into the abdomen. Specific dosing instructions are provided by the healthcare provider based on individual needs.
What should patients do if they experience side effects?
If any side effects occur, patients should promptly inform their healthcare provider. Serious reactions or persistent side effects should be immediately reported.
Can Plerixafor be used in all types of leukemia for stem cell harvesting?
Plerixafor injection 20 mg/ml is not recommended for stem cell harvesting in patients specifically diagnosed with leukemia.
Is regular monitoring necessary while on Plerixafor?
Yes, it’s important to regularly monitor white blood cell and platelet counts throughout the course of treatment with Plerixafor.
Are there any systemic reactions to watch out for during or after the injection?
Patients should be vigilant for potential systemic reactions like periorbital swelling, urticaria, breathing difficulties, or low oxygen levels, and should immediately inform healthcare providers if these occur.